Quality of Life and Disease Control at First Specialist Assessment in Atopic Dermatitis

Background/Objectives: Atopic dermatitis (AD) is associated with impaired quality of life and poor disease control. We aimed to describe patients attending their first specialist assessment in a tertiary AD unit and identify factors associated with poorer quality of life and poor perceived disease control. Methods: This single-centre cross-sectional study consecutively enrolled patients with AD and recorded clinical characteristics, treatment history, disease severity and patient-reported outcomes. Multivariable logistic regression assessed factors associated with Dermatology Life Quality Index (DLQI) > 10 and Atopic Dermatitis Control Tool (ADCT) ≥ 7. Complete-case analyses were supplemented by multiple imputation of missing covariates. Results: The study included 255 patients (mean age 37.4 years, 53.9% women). Flexural (33.3%) and diffuse (32.8%) phenotypes predominated, and 57.2% had at least one atopic comorbidity. Previous treatments included oral corticosteroids (44.0%), conventional systemic therapy (26.5%) and advanced therapy (6.9%). Among patients assessed, 25.0% had severe disease according to EASI and 31.9% according to SCORAD. A DLQI score > 10 was observed in 47/155 patients (30.3%) and an ADCT score ≥ 7 in 97/140 (69.3%). Greater itch intensity was associated with both outcomes, and sleep disturbance was associated with an ADCT score ≥ 7. The inverse association between a family history of atopy and a DLQI score > 10 showed a trend towards statistical significance (p = 0.058) after multiple imputation. Conclusions: Poor perceived control was common at the first specialist visit. The findings support assessing itch and sleep alongside clinical severity. The inverse association with a family history of atopy warrants further study.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-19
DOI
https://doi.org/10.3390/jcm15229073
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Quality of Life and Disease Control at First Specialist Assessment in Atopic Dermatitis

Salvador Arias‐Santiago, Trinidad Montero‐Vílchez, Raquel Sanabria-de la Torre, Julia Castro-Martín et al.
Journal of Clinical Medicine
Dermatology and Skin Diseases
article

Quality of Life and Disease Control at First Specialist Assessment in Atopic Dermatitis

Salvador Arias‐Santiago, Trinidad Montero‐Vílchez, Raquel Sanabria-de la Torre, Julia Castro-Martín, Andrea Isabel Rodriguez-Sanna, Clara A. Ureña-Paniego
article en

Abstract

Background/Objectives: Atopic dermatitis (AD) is associated with impaired quality of life and poor disease control. We aimed to describe patients attending their first specialist assessment in a tertiary AD unit and identify factors associated with poorer quality of life and poor perceived disease control. Methods: This single-centre cross-sectional study consecutively enrolled patients with AD and recorded clinical characteristics, treatment history, disease severity and patient-reported outcomes. Multivariable logistic regression assessed factors associated with Dermatology Life Quality Index (DLQI) > 10 and Atopic Dermatitis Control Tool (ADCT) ≥ 7. Complete-case analyses were supplemented by multiple imputation of missing covariates. Results: The study included 255 patients (mean age 37.4 years, 53.9% women). Flexural (33.3%) and diffuse (32.8%) phenotypes predominated, and 57.2% had at least one atopic comorbidity. Previous treatments included oral corticosteroids (44.0%), conventional systemic therapy (26.5%) and advanced therapy (6.9%). Among patients assessed, 25.0% had severe disease according to EASI and 31.9% according to SCORAD. A DLQI score > 10 was observed in 47/155 patients (30.3%) and an ADCT score ≥ 7 in 97/140 (69.3%). Greater itch intensity was associated with both outcomes, and sleep disturbance was associated with an ADCT score ≥ 7. The inverse association between a family history of atopy and a DLQI score > 10 showed a trend towards statistical significance (p = 0.058) after multiple imputation. Conclusions: Poor perceived control was common at the first specialist visit. The findings support assessing itch and sleep alongside clinical severity. The inverse association with a family history of atopy warrants further study.

Journal of Clinical MedicineVol. 15(22)
Universidad de Granada (ES), Instituto de Investigación Biosanitaria de Granada (ES), Hospital Universitario Virgen de las Nieves (ES)
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon